Collaboration: Begin with the End in Mind

Our goal is to advance the science as rapidly as possible and bring forward therapies and technologies that may benefit patients with prostate cancer. To develop biologically relevant models, to develop pharmacologically viable therapies, to dissect complex interwoven molecular mechanisms and to identify the molecular drivers of oncogenic processes, we work with structural biologists, medicinal chemists, bioinformatics, biochemists, molecular biologists, cell biologists, surgeons, pathologists and mathematicians. 

We are fortunate to have worked with an august group of scientific collaborators to bring forward our ideas and subject our research to the highest level of technical expertise. We have learned a great deal from our collaborators and have given much back in return. We have written and successfully competed for grants together, solved some molecular puzzles and have developed life-long relationships and deep friendships in this process. The journey has been and continues to be as rewarding as the spoils of victory.

We have had a long-standing collaboration with Jer-Tsong Hsieh, Ph.D., at UT Southwestern and share and have shared resources in our ongoing efforts to study prostate cancer. We have developed and are continuing to develop therapeutic agents with Jung-Mo Ahn, Ph.D., a superb medicinal chemist at UT Dallas.

We have a superb complementary and exciting ongoing collaboration with Wayne Tilley at U. Adelaide, Australia and have developed novel platforms for drug evaluation and discovery. We are working with Ralf Kittler, Ph.D., at UT Southwestern, Bob Matusik, Ph.D., at Vanderbilt University School of Medicine, and Steve Plymate, M.D., at the University of Washington to develop novel therapeutics in prostate cancer. Our collaborative efforts have been rewarding, highly effective and have expanded our horizons beyond prostate cancer, as evidenced by our ongoing work in breast cancer with Jason Carroll, Ph.D., University of Cambridge, UK, Carol Lange, Ph.D., University of Minnesota and Ratna Vadlamudi, Ph.D., UT Health Science Center, San Antonio.